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Abstract
Background: Cardiac resynchronization therapy (CRT) is generally associated with a low to moderate increase of
the left ventricular ejection fraction (LVEF). In some patients, however, LVEF improves remarkably and reaches near-
normal values. The aim of the present study was to further characterize these so called ‘super-responders’ with a
special focus on the extent of intra- and interventricular asynchrony before and after device implantation
compared to average responders.
Methods: 37 consecutive patients who underwent CRT device implantation according to current guidelines were
included in the study. Patients were examined by echocardiography before, one day after and six months after
device implantation. Pre-defined criterion for superior response to CRT was an LVEF increase > 15% after six months.
Results: At follow-up, eight patients (21.6%) were identified as super-responders. There were no significant differences
regarding age, gender, prevalence of ischemic heart disease and LVEF between average and super-responders at
baseline. After six months, LVEF had significantly increased from 26.7% ± 5.7% to 33.1% ± 7.9% (p <0 . 0 0 1 )i na v e r a g e
and from 24.0% ± 6.7% to 50.3% ± 7.4% (p < 0.001) in super-responders. Both groups showed a significant reduction of
QRS duration as well as LV end-diastolic and -systolic volumes under CRT. At baseline, the interventricular mechanical
delay (IVMD) was 53.7 ± 20.9 ms in average and 56.9 ± 22.4 ms in super-responders - representing a similar extent of
interventricular asynchrony in both groups (p = 0.713). CRT significantly reduced the IVMD to 20.3 ± 15.7 (p <0 . 0 0 1 )i n
average and to 19.8 ± 15.9 ms (p = 0.013) in super-responders with no difference between both groups (p = 0.858). As
a marker for intraventricular asynchrony, we assessed the longest intraventricular delay between six basal LV segments.
At baseline, there was no difference between average (86.2 ± 30.5 ms) and super-responders (78.8 ± 23.6 ms, p = 0.528).
CRT significantly reduced the longest intraventricular delay in both groups - with a significant difference between
average (66.2 ± 36.2 ms) and super-responders (32.5 ± 18.3 ms, p = 0.022). Multivariate logistic regression analysis
identified the longest intraventricular delay one day after device implantation as an independent predictor of superior
response to CRT (p =0 . 0 3 8 ) .
Conclusions: A significant reduction of the longest intraventricular delay correlates with superior response to CRT.
Background
Conduction disorders such as left bundle branch block
(LBBB) are a common finding in patients with chronic
heart failure (CHF) and frequently result in intra- and/
or interventricular asynchrony [1]. Since asynchrony
aggravates mitral regurgitation and disturbs left ventri-
cular (LV) contraction it consequently further promotes
LV remodeling. Cardiac resynchronization therapy
(CRT) aims at reverse remodeling by biventricular
pacing and has been demonstrated to remarkably
improve morbidity and mortality in CHF patients [2-4].
Only about 70% of all patients, however, show a signifi-
cant response to CRT [2-5]. As cardiac asynchrony
plays a major role in the rationale of CRT, a number of
studies tried to improve patient selection for CRT by
echocardiographic assessment of cardiac asynchrony.
Unfortunately, the largest multi-center study to date was
unable to confirm the effectiveness of twelve analyzed
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response to CRT [6]. Accordingly, patient selection for
CRT is currently based only on LVEF, QRS duration
and NYHA class [7].
Overall, the average LV ejection fraction (LVEF)
increase under CRT lies in the range of 3-5% [8]. In a
small subset of patients, however, CRT results in an
astonishing improvement of LV function by more than
15%. Recent studies reported that duration of heart fail-
ure symptoms, presence of LBBB, left ventricular
volumes and global longitudinal strain might serve as
predictors for superior response to CRT [9-12].
However, data on the extent of intra- and interventricu-
lar asynchrony in super-responders compared to average
responders is sparse.
Aim
The aim of our study was to analyze the characteristics
of the super-responders among our CRT patients with a
special focus on intra- and interventricular asynchrony.
Methods
Study population
Between April 2008 and December 2009, 37 patients
were included in this observational cohort study. Inclu-
sion criteria were indication for CRT according to
current guidelines (i.e., NYHA class III-IV under optimal
medical therapy, LVEF ≤ 3 5 % ,L Vd i l a t i o n ,a n dQ R S
duration ≥ 120 ms [7]), age > 18 years and ability to pro-
vide informed consent. Exclusion criteria were non-car-
diac comorbidities associated with a life-expectancy < 12
months. All patients with ischemic heart disease were
either tested for stress-induced ischemia by exercise tests
or underwent coronary angiography before CRT.
The study conforms to local university ethics guide-
lines and the principles outlined in the Declaration of
Helsinki.
Superior response to CRT was defined as an LVEF
increase > 15% six months after implantation.
Echocardiography
All patients were examined by echocardiography using a
Vivid 7 ultrasound system (GE Medical Systems, Hor-
ton, Norway) before as well as one day and six months
after device implantation. LVEF was calculated using
Simpson’s biplane approach [13].
Determination of asynchrony
Asynchrony was assessed before and one day after CRT
device implantation.
The right and left ventricular mechanical delays
(RVMD, LVMD) were determined by measuring the
interval between the beginning of the QRS complex and
the opening of the pulmonary and aortic valve,
respectively. Interventricular asynchrony was defined as
an interventricular mechanical delay (IVMD) > 40 ms
[14].
Intraventricular asynchrony was determined as
described previously [15]. Briefly, the interval between
the opening of the aortic valve (AVO) and the peak sys-
tolic velocity (S’) was measured using tissue Doppler
imaging (TDI) in six basal LV segments. Tissue synchro-
nization imaging (TSI) was used as an internal plausibil-
ity control and confirmed correct determination of S’ in
patients with a reduced acoustic window. The segment
with the shortest AVO-S’ interval served as a reference
segment as it most likely represents vital and intact
myocardium. To determine asynchronous segments, we
calculated the time differences between the AVO-S’
intervals of the reference and the other segments.
Regions were considered asynchronous when the calcu-
lated delay was above the upper limit of normal [15].
In addition, as a rough estimate of the extent of LV
intraventricular asynchrony, we calculated the longest
intraventricular delay, i.e., the delay between the seg-
ments with the shortest and longest AVO-S’ intervals.
Device implantation
LV leads were implanted by a transvenous approach via
the coronary sinus into the lateral or posterolateral car-
diac vein. All implantations were performed by two
experienced board-certified cardiologists.
AV- and VV-delay optimization
We performed AV- and VV-delay optimization in all
patients according to current guidelines [7]. If asyn-
chrony was not corrected under synchronous biventricu-
lar pacing, LV and RV pacing were programmed to the
delay resulting in the shortest intraventriclar delay (max-
imum programmed delay: 40 ms).
AV-delay optimization was performed using the itera-
tive method published by Cleland et al. [4]. In brief, we
initially programmed a long AV interval (e.g., 75% of
the intrinsic AV interval). The AV interval was then
decreased in 20 ms steps until we observed an A-wave
truncation. The AV interval was then incremented in 10
ms steps to obtain the optimal setting.
Statistics
Data are expressed as mean ± standard deviation (SD).
Statistical significance was calculated using z-tests, t-tests
and paired t-tests when appropriate (SigmaStat 3.0, SPSS,
Inc.). Multiple logistic regression analysis was performed
to identify variables that are associated with superior
response to CRT. An error probability of p <0 . 0 5w a s
considered statistically significant. Diagrams depict box
plots with the lower boundary indicating the 25th per-
centile, the upper boundary indicating the 75th percentile
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kers above and below the box represent the 90th and
10th percentiles, respectively. Statistical outliers are
marked by dots (SigmaPlot 9.0, SPSS, Inc.).
Results
Six months after device implantation, eight patients
(21.6%) were identified as super-responders. At baseline,
there were no statistically significant differences regard-
ing age, gender, prevalence of ICMP or the localization
of hypokinetic segments between average and super-
responders (Table 1).
At baseline, there was no statistically significant differ-
ence in the LV ejection fraction between average (26.7% ±
5.7%) and super-responders (24.0% ± 6.7%, p = 0.270,
Figure 1). The LV end-diastolic volume (LVEDV), how-
ever, was already significantly smaller at baseline in
patients who later showed superior response to CRT (p =
0.040, Table 2). Six months after implantation, LVEF,
LVEDV, and the LV end-systolic volume (LVESV) had sig-
nificantly improved compared to baseline parameters in
both groups. As expected, super-responders showed
significantly better LV geometry and systolic function
compared to average responders.
QRS duration and prevalence of intra- and interventri-
cular asynchrony (including the number of asynchro-
nous LV segments and the longest intraventricular
delay) did not differ significantly between both groups
at baseline (Table 3). Under CRT, QRS duration signifi-
cantly decreased in both groups compared to baseline
but again showed no difference between average and
super-responders. The right ventricular mechanical
delay (RVMD) increased significantly in average and
non-significantly in super-responders. Similarly, there
was a significant reduction of the left ventricular
mechanical delay (LVMD) in average and a non-
significant LVMD decrease in super-responders. Taken
together, this resulted in a significant reduction of the
interventricular delay in both average and super-respon-
ders. Consequently, the prevalence of interventricular
asynchrony decreased significantly in both groups. Inter-
estingly, there were no differences in RVMD, LVMD,
IVMD, and the prevalence of interventricular asyn-
chrony under CRT between both groups.
Intraventricular asynchrony (as defined by at least one
asynchronous LV segment) was detected in all but one
patient at baseline and there was no difference between
average and super-responders regarding the longest
intraventricular delay (86.2 ± 30.5 ms vs. 78.8 ± 23.6 ms,
p = 0.528). After implantation, the prevalence of intra-
ventricular asynchrony only non-significantly decreased
in both groups. In both average and super-responders,
however, the longest intraventricular delay decreased sig-
nificantly to 66.2 ± 36.2 ms (p < 0.001) and 32.5 ± 18.3
ms (p = 0.002), respectively - with a significant difference
between both groups (p =0 . 0 2 2 ,F i g u r e2 ) .T h e r ew e r e
no statistically significant differences regarding the locali-
zation of asynchronous segments between average and
super-responders - neither before nor after device
implantation. It is noteworthy, though, that average
responders had a more evenly distributed pattern of
asynchronous segments while super-responders had pri-
marily septal asynchrony at baseline (Figure 3).
Multiple logistic regression analysis based on gender,
age, etiology of heart failure, QRS duration, LVEDV,
IVMD, and the longest intraventricular delay at baseline
identified LVEDV as the only significant baseline predic-
t o ro fs u p e r i o rr e s p o n s et oC R T( p = 0.031). nterest-
ingly, multiple logistic regression analysis using gender,
age, etiology of heart failure as well as postoperative QRS
Table 1 Baseline characteristics of the study population
average
responders
super-
responders
p-
value
n 29 8 -
males, n (%) 24 (82.8%) 5 (62.5%) 0.455
age, years 69.7 ± 7.1 68.4 ± 7.6 0.647
ischemic cardiomyopathy,
n (%)
13 (44.8%) 2 (25.0%) 0.545
localization of hypokinesia
septal 0 (0%) 0 (0%) -
lateral 1 (3.4%) 0 (0%) 0.485
anterior 0 (0%) 0 (0%) -
inferior 3 (10.3%) 1 (12.5%) 0.639
anteroseptal 4 (13.8%) 1 (12.5%) 0.625
posterior 1 (3.4%) 0 (0%) 0.485
apical 1 (3.4%) 0 (0%) 0.485
global 20 (69.0%) 6 (75.0%) 0.915
Values are mean ± SD when appropriate.
Figure 1 LV ejection fraction (LVEF) of average and super-
responders at baseline and six months after device
implantation (CRT).
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revealed that the longest intraventricular delay one day
after device implantation might serve as a predictor for
superior response to CRT (p = 0.038).
Discussion
Cardiac resynchronization therapy represents a powerful
tool to improve morbidity and mortality of CHF patients
who remain symptomatic under optimal medical therapy
and meet current CRT inclusion criteria [7]. Unfortu-
nately, only about 70% of all CRT patients show a posi-
tive response after implantation which - given its high
costs and invasive nature with possible severe side
effects - is disappointingly low. As correction of cardiac
asynchrony is a major rationale of CRT, a number of
studies tried to improve patient selection by adding
asynchrony assessment to CRT inclusion criteria. Unfor-
tunately, however, the PROSPECT trial failed to confirm
the effectiveness of several established echocardiographic
asynchrony measures to predict response to CRT [6].
The aim of the present study was to further identify
characteristics of super-responders to CRT with a spe-
cial focus on inter- and intraventricular asynchrony.
Superior response to CRT as defined by an LVEF
increase > 15% six months after implantation was found
in 21.6% of our patients. This is consistent with previous
studies on super-responders which reported a prevalence
of 9.7-37.8% [9-12]. In these reports, super-responders
were generally found to be more often female and to suf-
fer less often from ischemic heart disease [10-12]. Here,
we also observed a similar, but non-significant trend in
our patients (Table 1). Significant differences between
super- and average responders were documented regard-
ing the LV end-diastolic volume at baseline as well as six
months after implantation (Table 2). This is in agreement
with earlier studies that also reported lower baseline LV
volumes in super-responders [9-11]. In our opinion, how-
ever, these results are unlikely to have a large impact on
patient selection in the clinical routine since they only
give us information on who is likely to benefit the most
from CRT. As these results do not imply that other
patients will not benefit from CRT at all, it would be false
to deny CRT to patients who do not share ‘super-respon-
der characteristics’ (e.g., male CHF patients with ischemic
cardiomyopathy and major LV dilation).
Analysis of interventricular asynchrony showed no dif-
ferences between average and super-responders at base-
line and after device implantation. In both groups,
biventricular pacing resulted in a significant reduction
of the interventricular mechanical delay (IVMD) and,
consequently, a correction of interventricular asyn-
chrony in almost all patients (Table 3). At baseline, the
overwhelming majority of patients had signs of intraven-
tricular asynchrony (Table 3). After implantation, intra-
ventricular asynchrony was still detectable in 79.3% of
the average and 50.0% of the super-responders repre-
senting a non-significant reduction in both groups
(p = 0.229). Interestingly, however, the longest intraven-
tricular delay was significantly reduced by 20.0 ± 25.4
ms in average and by 46.3 ± 26.7 ms in super-respon-
ders. This is consistent with a study by Antonio et al.
who reported a reduction of the longest intraventricular
Table 2 Patient characteristics at baseline and six months after device implantation
baseline six months after implantation
average responders super-responders p-value average responders super-responders p-value
LVEF, % 26.7 ± 5.7 24.0 ± 6.7 0.270 33.1 ± 7.9* 50.3 ± 7.4
# < 0.001
LVEDV, mL 199.8 ± 66.7 145.6 ± 49.4 0.040 155.0 ± 43.4* 103.4 ± 36.1
# 0.004
LVESV, mL 145.3 ± 47.9 110.1 ± 41.6 0.067 105.7 ± 36.1* 53.0 ± 23.1
# < 0.001
*) p < 0.05 vs. average responders at baseline,
#) p < 0.05 vs. super-responders at baseline
Table 3 QRS duration and cardiac asynchrony parameters before and one day after device implantation
before implantation after implantation
average responders super-responders p-value average responders super-responders p-value
QRS, ms 153.8 ± 17.6 150.0 ± 15.1 0.583 123.8 ± 12.4* 113.8 ± 11.9
# 0.086
RVMD, ms 88.8 ± 24.7 85.0 ± 26.2 0.708 111.6 ± 27.4* 105.5 ± 21.1 0.565
LVMD, ms 142.4 ± 25.3 141.9 ± 19.8 0.953 122.2 ± 32.2* 123.8 ± 19.7 0.567
IVMD, ms 53.7 ± 20.9 56.9 ± 22.4 0.713 20.3 ± 15.7* 19.8 ± 15.9
# 0.858
interventricular asynchrony, n (%) 19 (65.5%) 6 (75.0%) 0.936 2 (6.9%)* 1 (12.5%)
# 0.828
intraventricular asynchrony, n (%) 28 (96.6%) 8 (100.0%) 0.485 23 (79.3%) 4 (50.0%) 0.229
longest intraventricular delay, ms 86.2 ± 30.5 78.8 ± 23.6 0.528 66.2 ± 36.2* 32.5 ± 18.3
# 0.022
asynchronous segments, n (%) 2.3 ± 1.1 2.0 ± 0.8 0.518 2.0 ± 1.2 1.1 ± 1.6 0.150
*) p < 0.05 vs. average responders at baseline,
#) p < 0.05 vs. super-responders at baseline.
Values are mean ± SD when appropriate.
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super-responders [9]. With both groups having similar
baseline values, the longest intraventricular delay was
significantly shorter in our super-responders (32.5 ±
18.3 ms) compared to average responders (66.2 ± 36.2
ms) under CRT (p = 0.022). Furthermore, super-respon-
ders showed a trend for less asynchronous LV segments
(1.1 ± 1.6) than average responders (2.0 ± 1.2) at follow-
up. Not the least due to the low number of patients,
there were no significant differences regarding the loca-
tion of intraventricular asynchrony between both groups
(Figure 3).
In the PROSPECT trial, all tested asynchrony mea-
sures failed to predict response to CRT. To some
degree, this can be explained by the shortcomings of
current indices. In general, however, echocardiography
is per se not able to foresee the potential of the left ven-
tricle to undergo reverse remodeling. Accordingly, even
near-perfect assessment of asynchrony would not be
able to predict response to CRT. In the present study,
superior response to CRT did not correlate with the
extent of cardiac asynchrony at baseline. This finding
might help to understand the disappointing results of
the PROSPECT trial. Importantly, however, a greater
reduction of the longest intraventricular delay was asso-
ciated with superior response to CRT in our study. This
suggests that cardiac asynchrony is indeed a prerequisite
of successful CRT and its correction should remain in
our focus. In our opinion, asynchrony measurements
should not serve as predictors of response to CRT.
Instead, asynchrony quantification should be performed
to direct VV delay optimization - aimed at minimization
of the intraventricular delay.
Figure 2 The longest intraventricular delay in average and
super-responders at baseline and one day after device
implantation (CRT).
baseline
average responders
CRT
super-responders
baseline CRT
0%
50%
100%
prevalence
Figure 3 Prevalence of intraventricular asynchrony in six basal segments in average and super-responders before and one day after
device implantation (CRT). Upper panel: septal and lateral segments in the four chamber view. Middle panel: anterior and inferior segments in
the two chamber view. Lower Panel: anteroseptal and posterior segments in the three chamber view. Illustrations were originally created by
Patrick J. Lynch and C. Carl Jaffe, MD and modified with permission under the Creative Commons Attribution 2.5 License 2006.
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Our study is clearly limited by the low number of
patients. Furthermore, all data were collected at a single
center. We also did not assess global contractile reserve
which has recently been shown to correlate with
response to CRT [16].
Conclusions
Our results confirm once more that LV geometry at
baseline is an important factor for positive response to
CRT. In addition, our data suggest that not the initial
extent of cardiac asynchrony but rather a successful
reduction of the intraventricular delay correlates with
superior response to CRT. Pending confirmation of our
results by further studies, we speculate that routine
assessment of intraventricular asynchrony before and
after device implantation combined with a VV-delay
optimization aimed at reduction of the longest intraven-
tricular delay might help to improve response to CRT.
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